Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | AMICUS THERAPEUTICS, INC. | Prout Samantha
(Chief Accounting Officer) |
F | Common Stock | D | 7027 | $10.66 - $10.66 | $74,907 |
| 2024-04-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 7500 | $11.67 - $11.67 | $87,495 |
| 2024-04-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 7500 | $8.61 - $8.61 | $64,574 |
| 2024-03-15 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
F | Common Stock | D | 13375 | $11.48 - $11.48 | $153,545 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
F | Common Stock | D | 23577 | $13.65 - $13.65 | $321,826 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
A | Common Stock | A | 28810 | $0.00 - $0.00 | $0 |
| 2024-01-10 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
S | Common Stock | D | 31614 | $13.65 - $13.65 | $431,452 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
F | Common Stock | D | 36865 | $13.65 - $13.65 | $503,207 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
A | Common Stock | A | 57620 | $0.00 - $0.00 | $0 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Clark David Michael
(Chief People Officer) |
F | Common Stock | D | 8614 | $13.65 - $13.65 | $117,581 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Clark David Michael
(Chief People Officer) |
A | Common Stock | A | 13684 | $0.00 - $0.00 | $0 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Castelli Jeff
(Chief Development Officer) |
F | Common Stock | D | 10005 | $13.65 - $13.65 | $136,568 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Castelli Jeff
(Chief Development Officer) |
A | Common Stock | A | 14405 | $0.00 - $0.00 | $0 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
F | Common Stock | D | 12000 | $13.65 - $13.65 | $163,800 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
A | Common Stock | A | 16565 | $0.00 - $0.00 | $0 |
| 2024-03-07 | AMICUS THERAPEUTICS, INC. | SBLENDORIO GLENN
(Director) |
M | Common Stock | A | 15000 | $2.80 - $2.80 | $42,000 |
| 2024-02-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 15833 | $12.56 - $12.56 | $198,857 |
| 2024-02-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 15833 | $8.61 - $12.28 | $166,903 |
| 2024-02-01 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
S | Common Stock | D | 31614 | $12.62 - $12.62 | $398,918 |
| 2024-02-01 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
F | Common Stock | D | 21596 | $12.67 - $12.67 | $273,621 |
| 2024-01-16 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
S | Common Stock | D | 31614 | $12.78 - $12.78 | $404,105 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
F | Common Stock | D | 12000 | $13.65 - $13.65 | $163,800 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Clark David Michael
(Chief People Officer) |
F | Common Stock | D | 8614 | $13.65 - $13.65 | $117,581 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Castelli Jeff
(Chief Development Officer) |
F | Common Stock | D | 10005 | $13.65 - $13.65 | $136,568 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
F | Common Stock | D | 23577 | $13.65 - $13.65 | $321,826 |
| 2024-01-10 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
S | Common Stock | D | 31614 | $13.65 - $13.65 | $431,452 |
| 2024-01-09 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
F | Common Stock | D | 36865 | $13.65 - $13.65 | $503,207 |
| 2024-01-08 | AMICUS THERAPEUTICS, INC. | Clark David Michael
(Chief People Officer) |
S | Common Stock | D | 10110 | $14.00 - $14.00 | $141,540 |
| 2024-01-08 | AMICUS THERAPEUTICS, INC. | Prout Samantha
(Chief Accounting Officer) |
S | Common Stock | D | 32104 | $14.00 - $14.00 | $449,545 |
| 2024-01-04 | AMICUS THERAPEUTICS, INC. | Castelli Jeff
(Chief Development Officer) |
F | Common Stock | D | 3127 | $13.44 - $13.44 | $42,026 |
| 2024-01-02 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
S | Common Stock | D | 30000 | $14.21 - $14.21 | $426,219 |
| 2024-01-02 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
M | Common Stock | A | 30000 | $5.16 - $5.16 | $154,800 |
| 2024-01-02 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
F | Common Stock | D | 22382 | $13.53 - $14.24 | $307,787 |
| 2024-01-02 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
A | Common Stock | A | 63131 | $0.00 - $0.00 | $0 |
| 2023-12-31 | AMICUS THERAPEUTICS, INC. | Prout Samantha
(Chief Accounting Officer) |
F | Common Stock | D | 24669 | $14.19 - $14.24 | $350,118 |
| 2024-01-02 | AMICUS THERAPEUTICS, INC. | Prout Samantha
(Chief Accounting Officer) |
A | Common Stock | A | 25252 | $0.00 - $0.00 | $0 |
| 2023-12-26 | AMICUS THERAPEUTICS, INC. | Prout Samantha
(Chief Accounting Officer) |
S | Common Stock | D | 7659 | $14.00 - $14.00 | $107,228 |
| 2023-12-26 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
M | Common Stock | A | 35000 | $5.16 - $5.16 | $180,600 |
| 2023-12-19 | AMICUS THERAPEUTICS, INC. | Castelli Jeff
(Chief Development Officer) |
S | Common Stock | D | 19154 | $13.10 - $13.25 | $253,542 |
| 2023-12-18 | AMICUS THERAPEUTICS, INC. | Castelli Jeff
(Chief Development Officer) |
A | Common Stock | A | 8643 | $0.00 - $0.00 | $0 |
| 2023-12-15 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
S | Common Stock | D | 6043 | $12.66 - $12.66 | $76,515 |
| 2023-12-18 | AMICUS THERAPEUTICS, INC. | Rosenberg Ellen
(Chief Legal Officer) |
A | Common Stock | A | 9940 | $0.00 - $0.00 | $0 |
| 2023-11-15 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
S | Common Stock | D | 6043 | $10.84 - $10.84 | $65,497 |
| 2023-11-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 11700 | $10.97 - $10.97 | $128,391 |
| 2023-11-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 11700 | $2.94 - $2.94 | $34,398 |
| 2023-11-01 | AMICUS THERAPEUTICS, INC. | Crowley John F
(Executive Chairman) |
S | Common Stock | D | 6044 | $10.97 - $10.97 | $66,327 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |